JP2015227318A - 4-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine derivative and production method thereof - Google Patents
4-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine derivative and production method thereof Download PDFInfo
- Publication number
- JP2015227318A JP2015227318A JP2014114123A JP2014114123A JP2015227318A JP 2015227318 A JP2015227318 A JP 2015227318A JP 2014114123 A JP2014114123 A JP 2014114123A JP 2014114123 A JP2014114123 A JP 2014114123A JP 2015227318 A JP2015227318 A JP 2015227318A
- Authority
- JP
- Japan
- Prior art keywords
- trifluoromethyl
- trifluoroethoxy
- pyrimidine
- pyrimidine derivative
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VNSIDXFPSPQWDR-UHFFFAOYSA-N 4-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine Chemical class FC(COC1=NC=NC=C1C(F)(F)F)(F)F VNSIDXFPSPQWDR-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 229910052751 metal Inorganic materials 0.000 claims abstract description 20
- 239000002184 metal Substances 0.000 claims abstract description 20
- 150000004703 alkoxides Chemical class 0.000 claims abstract description 10
- NWFQLNPMKBHGIZ-UHFFFAOYSA-N FC(COC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F)(F)F Chemical compound FC(COC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F)(F)F NWFQLNPMKBHGIZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 claims abstract description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 125000006165 cyclic alkyl group Chemical group 0.000 claims abstract description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 28
- 239000003905 agrochemical Substances 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- 239000012776 electronic material Substances 0.000 abstract description 2
- 150000003230 pyrimidines Chemical class 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 24
- ZQBFAOFFOQMSGJ-UHFFFAOYSA-N hexafluorobenzene Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1F ZQBFAOFFOQMSGJ-UHFFFAOYSA-N 0.000 description 18
- 238000005481 NMR spectroscopy Methods 0.000 description 17
- 239000012043 crude product Substances 0.000 description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
- 229910052799 carbon Inorganic materials 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- CPCHRGFQWZMVNX-UHFFFAOYSA-N 5-(trifluoromethyl)pyrimidine Chemical group FC(F)(F)C1=CN=CN=C1 CPCHRGFQWZMVNX-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 8
- BDBXCHJGNCGZCK-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound C(C1=CC=CC=C1)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F BDBXCHJGNCGZCK-UHFFFAOYSA-N 0.000 description 8
- 235000019445 benzyl alcohol Nutrition 0.000 description 8
- 239000006227 byproduct Substances 0.000 description 8
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 8
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- IDRUEHMBFUJKAK-UHFFFAOYSA-N 2,4-dichloro-5-(trifluoromethyl)pyrimidine Chemical compound FC(F)(F)C1=CN=C(Cl)N=C1Cl IDRUEHMBFUJKAK-UHFFFAOYSA-N 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- OEPURHTYNZWSFB-UHFFFAOYSA-N C1=CC=C(C=C1)OC2=NC=C(C(=N2)OCC(F)(F)F)C(F)(F)F Chemical compound C1=CC=C(C=C1)OC2=NC=C(C(=N2)OCC(F)(F)F)C(F)(F)F OEPURHTYNZWSFB-UHFFFAOYSA-N 0.000 description 4
- LNDVZQWOVRGZKO-UHFFFAOYSA-N COC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound COC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F LNDVZQWOVRGZKO-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- HIMNWCDAABXOBV-UHFFFAOYSA-N 4-chloro-2-methoxy-5-(trifluoromethyl)pyrimidine Chemical compound COC1=NC=C(C(F)(F)F)C(Cl)=N1 HIMNWCDAABXOBV-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IGOVBFMPMQRRIJ-UHFFFAOYSA-N C(C)(C)(C)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound C(C)(C)(C)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F IGOVBFMPMQRRIJ-UHFFFAOYSA-N 0.000 description 3
- XDNZXEYFXLHMIU-UHFFFAOYSA-N C(C)(C)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound C(C)(C)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F XDNZXEYFXLHMIU-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- -1 Lichiu -Sec-butoxide Chemical compound 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- LAYTZLKFPPOBEL-UHFFFAOYSA-N 4-chloro-2-(4-nitrophenoxy)-5-(trifluoromethyl)pyrimidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=NC=C(C(F)(F)F)C(Cl)=N1 LAYTZLKFPPOBEL-UHFFFAOYSA-N 0.000 description 2
- CGMXIGLIMHWQLW-UHFFFAOYSA-N C1(CCCCC1)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound C1(CCCCC1)OC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F CGMXIGLIMHWQLW-UHFFFAOYSA-N 0.000 description 2
- RVESCXBZESTBCX-UHFFFAOYSA-N C1=CC=C(C=C1)COC2=NC(=NC=C2C(F)(F)F)OCC(F)(F)F Chemical compound C1=CC=C(C=C1)COC2=NC(=NC=C2C(F)(F)F)OCC(F)(F)F RVESCXBZESTBCX-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- URPRVBIULYUOOY-UHFFFAOYSA-N lithium;phenylmethoxymethylbenzene Chemical compound [Li].C=1C=CC=CC=1COCC1=CC=CC=C1 URPRVBIULYUOOY-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- NGQQUXXTDZADNX-UHFFFAOYSA-N 2,3,4,5-tetrachlorofuran Chemical compound ClC=1OC(Cl)=C(Cl)C=1Cl NGQQUXXTDZADNX-UHFFFAOYSA-N 0.000 description 1
- BQDJLAWUTBCDHK-UHFFFAOYSA-N 2-(trifluoromethyl)pyrimidine Chemical compound FC(F)(F)C1=NC=CC=N1 BQDJLAWUTBCDHK-UHFFFAOYSA-N 0.000 description 1
- XXUSEPOFBSZNLR-UHFFFAOYSA-N 2-chloro-4-methoxy-5-(trifluoromethyl)pyrimidine Chemical compound COC1=NC(Cl)=NC=C1C(F)(F)F XXUSEPOFBSZNLR-UHFFFAOYSA-N 0.000 description 1
- KVTQINCOFMGPIP-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxy]-2-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine Chemical compound FC(COC1=NC=C(C(=N1)OC(C)(C)C)C(F)(F)F)(F)F KVTQINCOFMGPIP-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- ZRCVHPXYHOTNJV-UHFFFAOYSA-N 4-phenoxy-2-(2,2,2-trifluoroethoxy)-5-(trifluoromethyl)pyrimidine Chemical compound FC(COC1=NC=C(C(=N1)OC1=CC=CC=C1)C(F)(F)F)(F)F ZRCVHPXYHOTNJV-UHFFFAOYSA-N 0.000 description 1
- LMNPKIOZMGYQIU-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-pyrimidine-2,4-dione Chemical compound FC(F)(F)C1=CNC(=O)NC1=O LMNPKIOZMGYQIU-UHFFFAOYSA-N 0.000 description 1
- LLPSANOSMMEMPB-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=NC=C(C(=N1)Cl)C(F)(F)F Chemical compound C(C1=CC=CC=C1)OC1=NC=C(C(=N1)Cl)C(F)(F)F LLPSANOSMMEMPB-UHFFFAOYSA-N 0.000 description 1
- SFCDPPQJADHDOY-UHFFFAOYSA-N C(CCCCC)OCCCCCC.[K] Chemical compound C(CCCCC)OCCCCCC.[K] SFCDPPQJADHDOY-UHFFFAOYSA-N 0.000 description 1
- DIKTVOLKQWJLJG-UHFFFAOYSA-N C(CCCCC)OCCCCCC.[Li] Chemical compound C(CCCCC)OCCCCCC.[Li] DIKTVOLKQWJLJG-UHFFFAOYSA-N 0.000 description 1
- XUPTVKORAROJNP-UHFFFAOYSA-N C(CCCCC)OCCCCCC.[Na] Chemical compound C(CCCCC)OCCCCCC.[Na] XUPTVKORAROJNP-UHFFFAOYSA-N 0.000 description 1
- MQLPLKXPMKESRX-UHFFFAOYSA-N C1=C(C(=NC(=N1)OCC(Cl)(Cl)Cl)OCC(Cl)(Cl)Cl)C(F)(F)F Chemical compound C1=C(C(=NC(=N1)OCC(Cl)(Cl)Cl)OCC(Cl)(Cl)Cl)C(F)(F)F MQLPLKXPMKESRX-UHFFFAOYSA-N 0.000 description 1
- HQWAJSJWQSBDCT-UHFFFAOYSA-N C1CCC(C1)OC2=NC=C(C(=N2)OCC(F)(F)F)C(F)(F)F Chemical compound C1CCC(C1)OC2=NC=C(C(=N2)OCC(F)(F)F)C(F)(F)F HQWAJSJWQSBDCT-UHFFFAOYSA-N 0.000 description 1
- ZKIPAZBNNIBOIR-UHFFFAOYSA-N CC(C)COC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound CC(C)COC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F ZKIPAZBNNIBOIR-UHFFFAOYSA-N 0.000 description 1
- XWVJKSHFXQTMPK-UHFFFAOYSA-N CC(C)OC1=NC(=NC=C1C(F)(F)F)OCC(F)(F)F Chemical compound CC(C)OC1=NC(=NC=C1C(F)(F)F)OCC(F)(F)F XWVJKSHFXQTMPK-UHFFFAOYSA-N 0.000 description 1
- BUSKOQNYQUEKKW-UHFFFAOYSA-N CCCCCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound CCCCCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F BUSKOQNYQUEKKW-UHFFFAOYSA-N 0.000 description 1
- XMQZDUSKTTUQSP-UHFFFAOYSA-N CCCCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound CCCCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F XMQZDUSKTTUQSP-UHFFFAOYSA-N 0.000 description 1
- ZNDQTJBCVKBTIE-UHFFFAOYSA-N CCCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound CCCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F ZNDQTJBCVKBTIE-UHFFFAOYSA-N 0.000 description 1
- XIXUMEFLGXIIRC-UHFFFAOYSA-N CCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F Chemical compound CCOC1=NC=C(C(=N1)OCC(F)(F)F)C(F)(F)F XIXUMEFLGXIIRC-UHFFFAOYSA-N 0.000 description 1
- VWKQSLIVUPNDKW-UHFFFAOYSA-N C[O-].[Na+].C[O-].[Li+] Chemical compound C[O-].[Na+].C[O-].[Li+] VWKQSLIVUPNDKW-UHFFFAOYSA-N 0.000 description 1
- ZSUUEAIMLBYEFC-UHFFFAOYSA-N ClC=1N=CC(CN=1)(C(F)(F)F)OCC1=CC=CC=C1 Chemical compound ClC=1N=CC(CN=1)(C(F)(F)F)OCC1=CC=CC=C1 ZSUUEAIMLBYEFC-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N Cyclohexane Natural products CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- XTLQJDSCZZMTFE-UHFFFAOYSA-N cyclohexyloxycyclohexane;lithium Chemical compound [Li].C1CCCCC1OC1CCCCC1 XTLQJDSCZZMTFE-UHFFFAOYSA-N 0.000 description 1
- AKOUBXPJKXUSKX-UHFFFAOYSA-N cyclohexyloxycyclohexane;potassium Chemical compound [K].C1CCCCC1OC1CCCCC1 AKOUBXPJKXUSKX-UHFFFAOYSA-N 0.000 description 1
- XZDNOKDWXGNNKZ-UHFFFAOYSA-N cyclohexyloxycyclohexane;sodium Chemical compound [Na].C1CCCCC1OC1CCCCC1 XZDNOKDWXGNNKZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- QVNHMTWRZDAWRE-UHFFFAOYSA-N ethylbenzene hexane Chemical compound C(C)C1=CC=CC=C1.CCCCCC QVNHMTWRZDAWRE-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000006005 fluoroethoxy group Chemical group 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- WBIUOUBFNXEKBA-UHFFFAOYSA-N lithium;2-methylpropan-1-olate Chemical compound [Li]OCC(C)C WBIUOUBFNXEKBA-UHFFFAOYSA-N 0.000 description 1
- LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- LTRVAZKHJRYLRJ-UHFFFAOYSA-N lithium;butan-1-olate Chemical compound [Li+].CCCC[O-] LTRVAZKHJRYLRJ-UHFFFAOYSA-N 0.000 description 1
- AZVCGYPLLBEUNV-UHFFFAOYSA-N lithium;ethanolate Chemical compound [Li+].CC[O-] AZVCGYPLLBEUNV-UHFFFAOYSA-N 0.000 description 1
- XAVQZBGEXVFCJI-UHFFFAOYSA-M lithium;phenoxide Chemical compound [Li+].[O-]C1=CC=CC=C1 XAVQZBGEXVFCJI-UHFFFAOYSA-M 0.000 description 1
- MXIRPJHGXWFUAE-UHFFFAOYSA-N lithium;propan-1-olate Chemical compound [Li+].CCC[O-] MXIRPJHGXWFUAE-UHFFFAOYSA-N 0.000 description 1
- HAUKUGBTJXWQMF-UHFFFAOYSA-N lithium;propan-2-olate Chemical compound [Li+].CC(C)[O-] HAUKUGBTJXWQMF-UHFFFAOYSA-N 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- LDIPVKABLDWRGC-UHFFFAOYSA-N phenylmethoxymethylbenzene;potassium Chemical compound [K].C=1C=CC=CC=1COCC1=CC=CC=C1 LDIPVKABLDWRGC-UHFFFAOYSA-N 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- PGMZELUBYYZRQZ-UHFFFAOYSA-L potassium sodium diphenoxide Chemical compound [Na+].[K+].[O-]C1=CC=CC=C1.[O-]C1=CC=CC=C1 PGMZELUBYYZRQZ-UHFFFAOYSA-L 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- CBMSDILKECEMOT-UHFFFAOYSA-N potassium;2-methylpropan-1-olate Chemical compound [K+].CC(C)C[O-] CBMSDILKECEMOT-UHFFFAOYSA-N 0.000 description 1
- MKNZKCSKEUHUPM-UHFFFAOYSA-N potassium;butan-1-ol Chemical compound [K+].CCCCO MKNZKCSKEUHUPM-UHFFFAOYSA-N 0.000 description 1
- ZUPDNLCLXSWMAE-UHFFFAOYSA-N potassium;butan-2-olate Chemical compound [K+].CCC(C)[O-] ZUPDNLCLXSWMAE-UHFFFAOYSA-N 0.000 description 1
- AWDMDDKZURRKFG-UHFFFAOYSA-N potassium;propan-1-olate Chemical compound [K+].CCC[O-] AWDMDDKZURRKFG-UHFFFAOYSA-N 0.000 description 1
- WQKGAJDYBZOFSR-UHFFFAOYSA-N potassium;propan-2-olate Chemical compound [K+].CC(C)[O-] WQKGAJDYBZOFSR-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- JYCDILBEUUCCQD-UHFFFAOYSA-N sodium;2-methylpropan-1-olate Chemical compound [Na+].CC(C)C[O-] JYCDILBEUUCCQD-UHFFFAOYSA-N 0.000 description 1
- SYXYWTXQFUUWLP-UHFFFAOYSA-N sodium;butan-1-olate Chemical compound [Na+].CCCC[O-] SYXYWTXQFUUWLP-UHFFFAOYSA-N 0.000 description 1
- VSCLJRSWEGZJNY-UHFFFAOYSA-N sodium;butan-2-olate Chemical compound [Na+].CCC(C)[O-] VSCLJRSWEGZJNY-UHFFFAOYSA-N 0.000 description 1
- LFQULJPVXNYWAG-UHFFFAOYSA-N sodium;phenylmethanolate Chemical compound [Na]OCC1=CC=CC=C1 LFQULJPVXNYWAG-UHFFFAOYSA-N 0.000 description 1
- RCOSUMRTSQULBK-UHFFFAOYSA-N sodium;propan-1-olate Chemical compound [Na+].CCC[O-] RCOSUMRTSQULBK-UHFFFAOYSA-N 0.000 description 1
- WBQTXTBONIWRGK-UHFFFAOYSA-N sodium;propan-2-olate Chemical compound [Na+].CC(C)[O-] WBQTXTBONIWRGK-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Abstract
Description
本発明は、新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法に関する。本発明の4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体は各種、医農薬や電子材料の合成原料として有用な化合物である。 The present invention relates to a novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and a method for producing the same. The 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative of the present invention is a compound useful as a raw material for synthesizing various medical and agricultural chemicals and electronic materials.
従来より、本発明の4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法は知られていない。
類似の化合物として、2−(4−ニトロフェノキシ)−4−クロロ−5−(トリフルオロメチル)ピリミジン及びその製造方法(例えば特許文献1参照)並びに2−メトキシ−4−クロロ−5−(トリフルオロメチル)ピリミジン及びその製造方法(例えば特許文献2参照)が知られている。
Conventionally, the 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative of the present invention and the production method thereof have not been known.
As similar compounds, 2- (4-nitrophenoxy) -4-chloro-5- (trifluoromethyl) pyrimidine and its production method (see, for example, Patent Document 1) and 2-methoxy-4-chloro-5- (tri Fluoromethyl) pyrimidine and a method for producing the same (see, for example, Patent Document 2) are known.
しかしながら、特許文献1に記載の方法は、4−ニトロフェノルを用い2−(4−ニトロフェノキシ)−4−クロロ−5−(トリフルオロメチル)ピリミジンを得る方法に限られるという課題があった。
一方、特許文献2に記載の方法は、目的物の2−メトキシ−4−クロロ−5−(トリフルオロメチル)ピリミジンと異性体の4−メトキシ−2−クロロ−5−(トリフルオロメチル)ピリミジンの混合物を得る方法であり、シリカゲルカラム精製により目的物の2−メトキシ−4−クロロ−5−(トリフルオロメチル)ピリミジンを得ており、工業的に実施が困難なシリカゲルカラム精製が必要という課題があった。
However, the method described in Patent Document 1 has a problem that it is limited to a method of obtaining 2- (4-nitrophenoxy) -4-chloro-5- (trifluoromethyl) pyrimidine using 4-nitrophenol.
On the other hand, the method described in Patent Document 2 includes the target 2-methoxy-4-chloro-5- (trifluoromethyl) pyrimidine and the isomer 4-methoxy-2-chloro-5- (trifluoromethyl) pyrimidine. The target 2-methoxy-4-chloro-5- (trifluoromethyl) pyrimidine is obtained by silica gel column purification, and it is necessary to purify the silica gel column, which is difficult to implement industrially. was there.
さらに、2,4−ジクロロ−5−(トリフルオロメチル)ピリミジンに各種金属アルコキシド等を反応させた場合、反応させる金属アルコキシドの種類により、組成は変動するが、生成物は2−位が置換されたものと4−位が置換されたものの混合物となるという課題があった。 Furthermore, when various metal alkoxides are reacted with 2,4-dichloro-5- (trifluoromethyl) pyrimidine, the composition varies depending on the type of metal alkoxide to be reacted, but the product is substituted at the 2-position. There was a problem that it became a mixture of the one and 4-position substituted.
本発明は、2−位又は4−位が置換された5−(トリフルオロメチル)ピリミジン誘導体の合成原料として有用な、2−位が置換された4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法の提供にある。 The present invention is useful as a raw material for synthesizing 5- (trifluoromethyl) pyrimidine derivatives substituted at 2-position or 4-position, and 4- (2,2,2-trifluoroethoxy substituted at 2-position. ) -5- (trifluoromethyl) pyrimidine derivatives and methods for producing the same.
本発明者らは、2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを原料とし、金属アルコキシド又は金属フェノキシドを反応させることにより、非常の高選択的に2−位がアルコキシで置換された新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体が得られることを見出し、本発明を完成させるに至った。 The present inventors use 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine as a raw material, and react with metal alkoxide or metal phenoxide to achieve a very high selection. Thus, it was found that a novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative substituted with alkoxy at the 2-position was obtained, and the present invention was completed. It was.
すなわち本発明は、下記一般式(1) That is, the present invention provides the following general formula (1)
(式(1)中、Rは、メチル基、エチル基、炭素数3〜6の直鎖分岐若しくは環式のアルキル基、フェニル基又はベンジル基を示す)
で表される4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体に関するもので、下記式(2)
(In the formula (1), R represents a methyl group, an ethyl group, a linear branched or cyclic alkyl group having 3 to 6 carbon atoms, a phenyl group, or a benzyl group)
4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by the following formula (2)
で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンと、下記一般式(3)
RO−M (3)
(式(3)中、Rは前記式(1)に同じ)
で表わされる金属アルコキシド又は金属フェノキシドを反応させ製造する方法を提供するものである。
2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine represented by the following general formula (3)
RO-M (3)
(In the formula (3), R is the same as the formula (1))
The metal alkoxide or metal phenoxide represented by these is made to react, and the manufacturing method is provided.
本発明により、医農薬の合成原料として有用な新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその高選択的製造方法が提供できる。 INDUSTRIAL APPLICABILITY According to the present invention, a novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative useful as a synthetic raw material for medical and agricultural chemicals and a highly selective production method thereof can be provided.
以下、本発明を詳細に説明する。
本発明の一般式(1)で表わされる4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体としては、具体的には例えば、2−メトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−エトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−iso−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−sec−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−iso−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−tert−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−ペントキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−cyclo−ペントキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−n−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−cylo−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−フェノキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン、2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン等を挙げることができる。
Hereinafter, the present invention will be described in detail.
Specific examples of the 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention include 2-methoxy-4- ( 2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-ethoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-n -Propoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-iso-propoxy-4- (2,2,2-trifluoroethoxy) -5- (tri Fluoromethyl) pyrimidine, 2-n-butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-sec-butoxy-4- (2, , 2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-iso-butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-tert- Butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-n-pentoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoro Methyl) pyrimidine, 2-cyclo-pentoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-n-hexyloxy-4- (2,2,2-tri) Fluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-cylo-hexyloxy-4- (2,2,2-trifluoroethoxy) -5- ( (Rifluoromethyl) pyrimidine, 2-phenoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine, 2-benzyloxy-4- (2,2,2-trifluoroethoxy) Examples include -5- (trifluoromethyl) pyrimidine.
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に使用する式(2)で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンは、例えば、工業的に入手可能な5−(トリフルオロメチル)ウラシルをオキシ塩化リン等より脱水及び塩素化し、2,4−ジクロロ−5−(トリフルオロメチル)ピリミジンを調製の後、さらに2,2,2−トリフルオロエタノールの金属塩を反応させること等により調製可能である。 2,4-bis (2,2,2-trifluoroethoxy) -5 represented by the formula (2) used for the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention -(Trifluoromethyl) pyrimidine is obtained by, for example, dehydrating and chlorinating commercially available 5- (trifluoromethyl) uracil from phosphorus oxychloride and the like to produce 2,4-dichloro-5- (trifluoromethyl) pyrimidine Can be prepared by reacting a metal salt of 2,2,2-trifluoroethanol.
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な一般式(3)で表わされる金属アルコキシド又は金属フェノキシドとしては、具体的には例えば、リチウムメトキシド、ナトリウムメトキシド、カリウムメトキシド、リチウムエトキシド、ナトリウムエトキシド、カリウムエトキシド、リチウム−n−プロポキシド、ナトリウム−n−プロポキシド、カリウム−n−プロポキシド、リチウム−iso−プロポキシド、ナトリウム−iso−プロポキシド、カリウム−iso−プロポキシド、リチウム−n−ブトキシド、ナトリウム−n−ブトキシド、カリウム−n−ブトキシド、リチウム−iso−ブトキシド、ナトリウム−iso−ブトキシド、カリウム−iso−ブトキシド、リチウム−sec−ブトキシド、ナトリウム−sec−ブトキシド、カリウム−sec−ブトキシド、リチウム−tert−ブトキシド、ナトリウム−tert−ブトキシド、カリウム−tert−ブトキシド、リチウム−n−ペントキシド、ナトリウム−n−ペントキシド、カリウム−n−ペントキシド、リチウム−n−ヘキシルオキシド、ナトリウム−n−ヘキシルオキシド、カリウム−n−ヘキシルオキシド、リチウム−cyclo−ヘキシルオキシド、ナトリウム−cyclo−ヘキシルオキシド、カリウム−cyclo−ヘキシルオキシド、リチウムフェノキシド、ナトリウムフェノキシド、カリウムフェノキシド、リチウムベンジロキシド、ナトリウムベンジロキシド、カリウムベンジロキシド等が挙げられる。 As the metal alkoxide or metal phenoxide represented by the general formula (3) applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention, specifically, for example, lithium methoxy Sodium methoxide, potassium methoxide, lithium ethoxide, sodium ethoxide, potassium ethoxide, lithium-n-propoxide, sodium-n-propoxide, potassium-n-propoxide, lithium-iso-propoxide, Sodium-iso-propoxide, potassium-iso-propoxide, lithium-n-butoxide, sodium-n-butoxide, potassium-n-butoxide, lithium-iso-butoxide, sodium-iso-butoxide, potassium-iso-butoxide, Lichiu -Sec-butoxide, sodium-sec-butoxide, potassium-sec-butoxide, lithium-tert-butoxide, sodium-tert-butoxide, potassium-tert-butoxide, lithium-n-pentoxide, sodium-n-pentoxide, potassium-n -Pentoxide, lithium-n-hexyl oxide, sodium-n-hexyl oxide, potassium-n-hexyl oxide, lithium-cyclo-hexyl oxide, sodium-cyclo-hexyl oxide, potassium-cyclo-hexyl oxide, lithium phenoxide, sodium phenoxide Potassium phenoxide, lithium benzyloxide, sodium benzyloxide, potassium benzyloxide and the like.
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な一般式(3)で表わされる金属アルコキシド又は金属フェノキシドの使用量は、反応に具する式(2)で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンに対して、1.0モル倍量〜1.5モル倍量の範囲である。 The amount of the metal alkoxide or metal phenoxide represented by the general formula (3) applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention is determined by the formula ( 2) In the range of 1.0 mol times to 1.5 mol times the amount of 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine represented by 2) is there.
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な一般式(3)で表わされる金属アルコキシド又は金属フェノキシドは、市販されているものであればそのまま用いても良いし、市販されていないものは該当するアルコール類又はフェノールに、例えば、水素化リチウム、水素化ナトリウム、水素化カリウム、n−ブチルリチウム、tert−ブチルリチウム、リチウム ヘキサメチルジシラジド、ナトリウム ヘキサメチルジシラジド、カリウム ヘキサメチルジシラジド等の金属試剤を、アルコール類又はフェノールに対して0.7モル倍量〜1.0モル倍量使用し調製しても良い。 If the metal alkoxide or metal phenoxide represented by the general formula (3) applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention is commercially available, it is used as it is. Those that are not commercially available may be used as appropriate alcohols or phenols, for example, lithium hydride, sodium hydride, potassium hydride, n-butyl lithium, tert-butyl lithium, lithium hexamethyldisilazide. Metal reagents such as sodium hexamethyldisilazide, potassium hexamethyldisilazide, etc. may be prepared by using 0.7 mol times to 1.0 mol times the amount of alcohol or phenol.
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造に適用可能な溶剤としては、反応に不活性な溶剤であればあらゆるものが使用可能であるが、例えば、ジエチルエーテル、ジ−iso−プロピルエーテル、メチル−tert−ブチルエーテル、メチル−cyclo−ペンチルエーテル、テトラヒドロフラン等のエーテル系溶剤、ペンタン、ヘキサン、cyclo−ヘキサン等の脂肪族炭化水素系溶剤、ベンゼン、トルエン、エチルベンゼン、キシレン、メシチレン、クメン等の芳香族炭化水素系溶剤等が挙げられ、反応に具する式(2)で表わされる2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンに対して、2重量倍量〜100重量倍量使用する。また、これら溶剤は2種以上を混合して用いても良い。 As the solvent applicable to the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention, any solvent can be used as long as it is inert to the reaction. Ether solvents such as diethyl ether, di-iso-propyl ether, methyl-tert-butyl ether, methyl-cyclo-pentyl ether, tetrahydrofuran, aliphatic hydrocarbon solvents such as pentane, hexane, cyclo-hexane, benzene, toluene, Examples include aromatic hydrocarbon solvents such as ethylbenzene, xylene, mesitylene, cumene, etc., and 2,4-bis (2,2,2-trifluoroethoxy) -5 represented by the formula (2) included in the reaction. 2 to 100 times the amount of (trifluoromethyl) pyrimidine is used. Moreover, you may use these solvents in mixture of 2 or more types.
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造の反応温度及び時間としては、反応に用いる金属アルコキシドの種類、溶剤の種類及び基質濃度により異なるが、通常−20℃〜80℃の温度範囲で、1時間〜48時間反応を行うことにより反応が完結する。
本発明の一般式(1)で表わされる5−(トリフルオロメチル)ピリミジン誘導体の製造後の後処理としては、周知の方応で実施可能で、例えば、飽和塩化アンモニウム水溶液で中和、ジクロロメタン等の溶剤で抽出、硫酸ナトリウム上で乾燥、ろ過、濃縮することにより、一般式(1)で表わされる4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体を得る。
The reaction temperature and time for producing the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention vary depending on the type of metal alkoxide used in the reaction, the type of solvent, and the substrate concentration. The reaction is completed by carrying out the reaction for 1 hour to 48 hours in a temperature range of 20 ° C to 80 ° C.
The post-treatment after the production of the 5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) of the present invention can be carried out by a well-known method, such as neutralization with a saturated aqueous ammonium chloride solution, dichloromethane or the like. The 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by the general formula (1) was obtained by extraction with a solvent of the above, drying over sodium sulfate, filtration, and concentration. obtain.
以下実施例により本発明を具体的に説明するが、本発明はこれらの実施例のみに限定されるものではない。
なお、分析に当たっては下記機器を使用した。
1H−NMR,19F−NMR,13C−NMR:ブルカー社(BRUKER)製AVANCE II 400。
GC-MS:嶋津製作所製GCMS−QP2010Plus。
元素分析:ヤナコ社製CHNコーダー MT−6。
EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited only to these examples.
The following equipment was used for the analysis.
1 H-NMR, 19 F-NMR, 13 C-NMR: AVANCE II 400 manufactured by Bruker.
GC-MS: Shimadzu GCMS-QP2010Plus.
Elemental analysis: CHN coder MT-6 manufactured by Yanaco.
参考例1 2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの調製
窒素気流下、撹拌子を備えた200mLのナス型フラスコに、2,2,2−トリフルオロエタノール(5.99g,59.9mmol)及びテトラヒドロフラン(85mL)を仕込み、−20℃に冷却の後、n−ブチルリチウム(1.6M−ヘキサン溶液,34.5mL,55.2mmol)を添加し、同温度で30分撹拌した。次いでこれに、2,4−ジクロロ−5−(トリフルオロメチル)ピリミジン(5.00g,23.0mmol)を添加し、同温度で30分撹拌の後、昇温し、40℃で24時間反応を行った。
Reference Example 1 Preparation of 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine In a 200 mL eggplant-shaped flask equipped with a stirrer under a nitrogen stream, 2,2, 2-Trifluoroethanol (5.99 g, 59.9 mmol) and tetrahydrofuran (85 mL) were charged, cooled to −20 ° C., and then n-butyllithium (1.6 M-hexane solution, 34.5 mL, 55.2 mmol). And stirred at the same temperature for 30 minutes. Next, 2,4-dichloro-5- (trifluoromethyl) pyrimidine (5.00 g, 23.0 mmol) was added thereto, and the mixture was stirred at the same temperature for 30 minutes, then warmed and reacted at 40 ° C. for 24 hours. Went.
反応終了後、反応液に飽和の塩化アンモニウム水溶液(30mL)を添加、減圧下濃縮、ジクロロメタン(30ml×3回)抽出、硫酸ナトリウム上で乾燥、ろ過、減圧濃縮することにより粗製物を得た。
得られた粗製物は、シリカゲル床(10g、溶離液ジクロロメタン)で精製、濃縮することにより目的物の2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(7.22g,21.0mmol,収率91%)を無色透明液体として得た。
1H−NMR(CDCl3,400MHz)δ8.60(d,J=0.8Hz,1H),4.91(q,J=4.9Hz,2H),4.85(q,J=4.8Hz,2H)。
19F−NMR(CDCl3,376MHz)δ−63.80,−74.82(t,J=7.5Hz),−74.89(t,J=7.5Hz)。
13C−NMR(CDCl3,100MHz)δ167.07,165.00,158.38(q,J=4.7Hz),122.99(q,J=275.8Hz),122.74(q,J=275.6Hz),122.28(q,J=269.4Hz),108.05(q,J=34.7Hz),64.39(q,J=36.7Hz),63.39(q,J=37.2Hz)。
GC−MS(m/z):344(M+,45),325(58),275(100),246(93),163(90),83(95)。
元素分析
計算値:炭素(31.41%)、水素(1.46%)、窒素(8.14%)。
測定値:炭素(31.32%)、水素(1.46%)、窒素(8.16%)。
After completion of the reaction, a saturated aqueous ammonium chloride solution (30 mL) was added to the reaction solution, concentrated under reduced pressure, extracted with dichloromethane (30 ml × 3 times), dried over sodium sulfate, filtered, and concentrated under reduced pressure to obtain a crude product.
The obtained crude product was purified by silica gel bed (10 g, eluent dichloromethane) and concentrated to give the desired 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl). Pyrimidine (7.22 g, 21.0 mmol, 91% yield) was obtained as a colorless transparent liquid.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.60 (d, J = 0.8 Hz, 1H), 4.91 (q, J = 4.9 Hz, 2H), 4.85 (q, J = 4. 8Hz, 2H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.80, −74.82 (t, J = 7.5 Hz), −74.89 (t, J = 7.5 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 167.07, 165.00, 158.38 (q, J = 4.7 Hz), 122.99 (q, J = 275.8 Hz), 122.74 (q, J = 275.6 Hz), 122.28 (q, J = 269.4 Hz), 108.05 (q, J = 34.7 Hz), 64.39 (q, J = 36.7 Hz), 63.39 ( q, J = 37.2 Hz).
GC-MS (m / z): 344 (M + , 45), 325 (58), 275 (100), 246 (93), 163 (90), 83 (95).
Elemental analysis calculated: carbon (31.41%), hydrogen (1.46%), nitrogen (8.14%).
Measurements: carbon (31.32%), hydrogen (1.46%), nitrogen (8.16%).
実施例1 2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(4)の調製 Example 1 Preparation of 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (4)
撹拌子を備え、窒素置換した50mLのナス型フラスコに、ベンジルアルコール(0.310g,2.91mmol)及びテトラヒドロフラン(20mL)を仕込み、−20℃に冷却の後、n−ブチルリチウム(1.6M−ヘキサン溶液,1.82mL,2.91mmol)を添加し、同温度で30分撹拌した。次いで、参考例1で調製した2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)を添加し、同温度で30分撹拌の後、室温に戻し、12時間反応を行った。反応終了後、飽和塩化アンモニウム水溶液(10mL)を添加、減圧濃縮によりテトラヒロロフランを留去、ジクロロメタン(10mL×3回)抽出、有機層を合わせて、硫酸ナトリウム上で乾燥、ろ過、次いで濃縮することにより、粗製物の2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを微淡黄色固体として得た(1.21g)。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率95%、収率92%で、副生物の2−(2,2,2−トリフルオロエトキシ)−4−ベンジロキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.2%含有されていた。 Benzyl alcohol (0.310 g, 2.91 mmol) and tetrahydrofuran (20 mL) were charged into a 50 mL eggplant type flask equipped with a stir bar and purged with nitrogen. After cooling to −20 ° C., n-butyllithium (1.6 M -Hexane solution, 1.82 mL, 2.91 mmol) was added, and the mixture was stirred at the same temperature for 30 minutes. Next, 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) prepared in Reference Example 1 was added, and 30 at the same temperature. After stirring for a minute, the temperature was returned to room temperature and the reaction was carried out for 12 hours. After completion of the reaction, a saturated aqueous solution of ammonium chloride (10 mL) is added. Tetrachlorofuran is distilled off by concentration under reduced pressure, extraction with dichloromethane (10 mL × 3 times), the organic layers are combined, dried over sodium sulfate, filtered, and concentrated. This gave crude 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine as a slightly pale yellow solid (1.21 g). In 19 F-NMR measurement using hexafluorobenzene as an internal standard, the obtained crude product was converted into 95% by 92% yield and by-product 2- (2,2,2-trifluoroethoxy). -4-Benzyloxy-5- (trifluoromethyl) pyrimidine contained 1.2% in terms of yield.
さらに得られた粗製物を、エチルベンゼン−ヘキサンを用いた再結晶を行うことにより、精製2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを白色固体として得た(0.77g,収率75%、純度99%)。
1H−NMR(CDCl3,400MHz)δ8.58(d,J=0.8Hz,1H),7.47−7.35(m,5H),5.47(s,2H),4.85(q,J=8.0Hz,2H)。
19F−NMR(CDCl3,376MHz)δ−63.71,−75.03(t,J=7.5Hz)。
13C−NMR(CDCl3,100MHz)δ166.58,166.28,158.45(q,J=4.7Hz),135.52,128.84,128.73,128.40,122.82(q,J=275.2Hz),122.58(q,J=269.2Hz),106.49(q,J=34.5Hz),70.60,63.01(q,J=37.0Hz)。
GC−MS(m/z)352(10,M+),351(8),269(7),246(35),107(6),91(100),65(21)。
元素分析
計算値:炭素(47.74%)、水素(2.86%)、窒素(7.95%)。
測定値:炭素(47.62%)、水素(2.87%)、窒素(7.93%)。
Further, the obtained crude product was recrystallized from ethylbenzene-hexane to obtain purified 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine in white. Obtained as a solid (0.77 g, 75% yield, 99% purity).
1 H-NMR (CDCl 3 , 400 MHz) δ 8.58 (d, J = 0.8 Hz, 1H), 7.47-7.35 (m, 5H), 5.47 (s, 2H), 4.85 (Q, J = 8.0 Hz, 2H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.71, −75.03 (t, J = 7.5 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.58, 166.28, 158.45 (q, J = 4.7 Hz), 135.52, 128.84, 128.73, 128.40, 122.82 (Q, J = 275.2 Hz), 122.58 (q, J = 269.2 Hz), 106.49 (q, J = 34.5 Hz), 70.60, 63.01 (q, J = 37. 0 Hz).
GC-MS (m / z) 352 (10, M + ), 351 (8), 269 (7), 246 (35), 107 (6), 91 (100), 65 (21).
Elemental analysis calculated: carbon (47.74%), hydrogen (2.86%), nitrogen (7.95%).
Measurements: carbon (47.62%), hydrogen (2.87%), nitrogen (7.93%).
実施例2 2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの調製
実施例1と同じ反応装置に、水素化ナトリウム(60%油性、0.163g,4.07mmol)及びテトラヒドロフラン(40mL)を仕込み、0℃に冷却の後、ベンジルアルコール(0.450g,4.22mmol)を添加し、同温度で30分撹拌した。次いで、参考例1で調製した2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)を添加し、同温度で24時間反応を行った。反応収率後、実施例1と同じ後処理操作を行い、粗製物の2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを微淡黄色固体として得た(1.27g)。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率100%、収率96%、副生物の2−(2,2,2−トリフルオロエトキシ)−4−ベンジロキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.5%含有されていた。
Example 2 Preparation of 2-Benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine In the same reactor as in Example 1, sodium hydride (60% oily, 0. 163 g, 4.07 mmol) and tetrahydrofuran (40 mL) were charged, and after cooling to 0 ° C., benzyl alcohol (0.450 g, 4.22 mmol) was added and stirred at the same temperature for 30 minutes. Next, 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) prepared in Reference Example 1 was added, and 24 hours at the same temperature. Time reaction was performed. After the reaction yield, the same post-treatment operation as in Example 1 was carried out, and crude 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a slightly pale yellow solid. (1.27 g). The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 100%, the yield was 96%, and the byproduct 2- (2,2,2-trifluoroethoxy)- 4-Benzyloxy-5- (trifluoromethyl) pyrimidine contained 1.5% in terms of yield.
実施例3 2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの調製
実施例1と同じ反応装置に、ベンジルアルコール(0.403g,3.78mmol)及びテトラヒドロフラン(10mL)を仕込み、−10℃に冷却の後、カリウム ヘキサメチルジシラジド(1.0M−テトラヒドロフラン溶液、3.06mL,3.06mmol)を添加し、同温度で30分撹拌した。次いで、参考例1で調製した2,4−ビス(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)を添加し、同温度で24時間反応を行った。反応収率後、実施例1と同じ後処理操作を行い、粗製物の2−ベンジロキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンを微淡黄色固体として得た(1.19g)。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率99%、収率95%、副生物の2−(2,2,2−トリフルオロエトキシ)−4−ベンジロキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.8%含有されていた。
Example 3 Preparation of 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine To the same reactor as in Example 1, benzyl alcohol (0.403 g, 3.78 mmol) was prepared. ) And tetrahydrofuran (10 mL), and after cooling to −10 ° C., potassium hexamethyldisilazide (1.0 M-tetrahydrofuran solution, 3.06 mL, 3.06 mmol) was added and stirred at the same temperature for 30 minutes. . Next, 2,4-bis (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) prepared in Reference Example 1 was added, and 24 hours at the same temperature. Time reaction was performed. After the reaction yield, the same post-treatment operation as in Example 1 was carried out, and crude 2-benzyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a slightly pale yellow solid. (1.19 g). The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 99%, the yield was 95%, and the byproduct 2- (2,2,2-trifluoroethoxy)- 4-Benzyloxy-5- (trifluoromethyl) pyrimidine contained 1.8% in terms of yield.
実施例4 2−メトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(5)の調製 Example 4 Preparation of 2-methoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (5)
実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてメタノール(0.092g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−メトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(0.82g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率92%、収率89%で、副生物の2−(2,2,2−トリフルオロエトキシ)−4−メトキシ−5−(トリフルロメチル)ピリミジンが収率換算で2.3%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.58(d,J=0.8Hz,1H),4.90(q,J=8.1Hz,2H),4.08(s,3H)。
19F−NMR(CDCl3,376MHz)δ−63.60,−74.94(t,J=8.1Hz)。
13C−NMR(CDCl3,100MHz)δ166.93,166.54,158.49(q,J=4.7Hz),122.86(q,J=275.6Hz),122.63(q,J=268.9Hz),106.25(q,J=34.5Hz),62.88(q,J=37.1Hz),55.86。
GC−MS m/z276(49,M+),275(27),257(24),246(100),163(37),143(32),91(27),83(23),69(21)。
元素分析
計算値:炭素(34.80%)、水素(2.19%)、窒素(10.14%)。
測定値:炭素(34.71%)、水素(2.19%)、窒素(10.13%)。
The same operation as in Example 1 was carried out except that methanol (0.092 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-methoxy-4- (2 , 2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (0.82 g) was obtained as a colorless transparent liquid. In the 19 F-NMR measurement using hexafluorobenzene as an internal standard, the obtained crude product was converted into a by-product 2- (2,2,2-trifluoroethoxy) with a conversion rate of 92% and a yield of 89%. -4-Methoxy-5- (trifluoromethyl) pyrimidine was contained 2.3% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.58 (d, J = 0.8 Hz, 1H), 4.90 (q, J = 8.1 Hz, 2H), 4.08 (s, 3H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.60, −74.94 (t, J = 8.1 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.93, 166.54, 158.49 (q, J = 4.7 Hz), 122.86 (q, J = 275.6 Hz), 122.63 (q, J = 268.9 Hz), 106.25 (q, J = 34.5 Hz), 62.88 (q, J = 37.1 Hz), 55.86.
GC-MS m / z 276 (49, M + ), 275 (27), 257 (24), 246 (100), 163 (37), 143 (32), 91 (27), 83 (23), 69 ( 21).
Elemental analysis calculated: carbon (34.80%), hydrogen (2.19%), nitrogen (10.14%).
Measurements: carbon (34.71%), hydrogen (2.19%), nitrogen (10.13%).
実施例5 2−iso−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(6)の調製 Example 5 Preparation of 2-iso-propoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (6)
実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてiso−プロパノール(0.175g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−iso−プロポキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(0.98g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率96%、収率94%、副生物の2−(2,2,2−トリフルオロエトキシ)−4−iso−プロポキシ−5−(トリフルロメチル)ピリミジンが収率換算で1.3%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.55(d,J=0.8Hz,1H),5.35(dq,J=6.4,6.3Hz,1H),4.90(q,J=8.1Hz,2H),1.42(d,J=6.4Hz,6H)。
19F−NMR(CDCl3,376MHz)δ−63.30,−74.82(t,J=9.4Hz)。
13C−NMR(CDCl3,100MHz)δ166.52,166.11,158.43(q,J=4.7Hz),122.89(q,J=275.7Hz),122.69(q,J=268.7Hz),105.83(q,J=34.0Hz),72.58,62.89(q,J=37.0Hz),21.75。
GC−MS(m/z)304(2,M+),289(12),263(94),246(100),243(27),223(16),193(35),164(28),136(33),83(23)。
元素分析
計算値:炭素(39.48%)、水素(3.31%)、窒素(9.21%)。
測定値:炭素(39.42%)、水素(3.31%)、窒素(9.19%)。
The same procedure as in Example 1 was performed except that iso-propanol (0.175 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-iso-propoxy- A crude product (0.98 g) of 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a colorless transparent liquid. The obtained crude product was subjected to a 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 96%, the yield was 94%, and the byproduct 2- (2,2,2-trifluoroethoxy)- 4-iso-propoxy-5- (trifluoromethyl) pyrimidine contained 1.3% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.55 (d, J = 0.8 Hz, 1H), 5.35 (dq, J = 6.4, 6.3 Hz, 1H), 4.90 (q, J = 8.1 Hz, 2H), 1.42 (d, J = 6.4 Hz, 6H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.30, −74.82 (t, J = 9.4 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.52, 166.11, 158.43 (q, J = 4.7 Hz), 122.89 (q, J = 275.7 Hz), 122.69 (q, J = 268.7 Hz), 105.83 (q, J = 34.0 Hz), 72.58, 62.89 (q, J = 37.0 Hz), 21.75.
GC-MS (m / z) 304 (2, M + ), 289 (12), 263 (94), 246 (100), 243 (27), 223 (16), 193 (35), 164 (28) 136 (33), 83 (23).
Elemental analysis calculated: carbon (39.48%), hydrogen (3.31%), nitrogen (9.21%).
Measurements: carbon (39.42%), hydrogen (3.31%), nitrogen (9.19%).
実施例6 2−tert−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(7)の調製 Example 6 Preparation of 2-tert-butoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (7)
実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてtert−ブタノール(0.216g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−tert−ブトキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(0.94g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率93%、収率93%、副生物の2−(トリフルオロエトキシ)−4−tert−ブトキシ−5−(トリフルロメチル)ピリミジンは観測されなかった。
1H−NMR(CDCl3,400MHz)δ8.54(d,J=0.8Hz,1H),4.85(q,J=8.1Hz,2H),1.66(s,9H)。
19F−NMR(CDCl3,376MHz)δ−63.70,−74.87(t,J=9.4Hz)。
13C−NMR(CDCl3,100MHz)δ166.12(d,J=1.3Hz),165.96,158.06(q,J=4.7Hz),122.91(q,J=275.5Hz),122.79(q,J=268.7Hz),105.51(q,J=34.5Hz),69.03,62.98(q,J=36.9Hz),28.30。
GC−MS(m/z)303(4),263(91),243(15),223(8),83(9),57(100)。
The same operation as in Example 1 was performed except that tert-butanol (0.216 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-tert-butoxy- A crude product (0.94 g) of 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine was obtained as a colorless transparent liquid. The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 93%, the yield was 93%, and the by-product 2- (trifluoroethoxy) -4-tert-butoxy- 5- (Trifluoromethyl) pyrimidine was not observed.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.54 (d, J = 0.8 Hz, 1H), 4.85 (q, J = 8.1 Hz, 2H), 1.66 (s, 9H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.70, −74.87 (t, J = 9.4 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.12 (d, J = 1.3 Hz), 165.96, 158.06 (q, J = 4.7 Hz), 122.91 (q, J = 275. 5 Hz), 122.79 (q, J = 268.7 Hz), 105.51 (q, J = 34.5 Hz), 69.03, 62.98 (q, J = 36.9 Hz), 28.30.
GC-MS (m / z) 303 (4), 263 (91), 243 (15), 223 (8), 83 (9), 57 (100).
実施例7 2−cyclo−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(8)の調製 Example 7 Preparation of 2-cyclo-hexyloxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (8)
実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてcyclo−ヘキサノール(0.291g,2.91mmol)を用いた以外、実施例1と同じ操作を行い、2−cyclo−ヘキシルオキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(1.25g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率97%、収率96%、副生物の2−(トリフルオロエトキシ)−4−cyclo−ヘキシルオキシ−5−(トリフルロメチル)ピリミジンが収率換算で0.7%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.54(d,J=0.8Hz,1H),5.12−5.02(m,1H),4.87(q,J=8.1Hz,2H),2.07−1.27(m,10H)。
19F−NMR(CDCl3,376MHz)δ−63.55,−74.99(t,J=8.1Hz)。
13C−NMR(CDCl3,100MHz)δ166.53,166.12,158.38(q,J=4.7Hz),122.89(q,J=275.7Hz),122.69(q,J=268.9Hz),105.79(q,J=34.4Hz),77.55,62.90(q,J=37.0Hz),31.62,25.49,23.98。
GC−MS(m/z)263(100),247(21),246(20),243(16),223(7),83(22%)。
元素分析
計算値:炭素(45.36%)、水素(4.10%)、窒素(8.14%)。
測定値:炭素(45.31%)、水素(4.11%)、窒素(8.12%)。
The same operation as in Example 1 was carried out except that cyclohexanol (0.291 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1, and 2-cyclo-hexyloxy was used. A crude product of -4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (1.25 g) was obtained as a colorless transparent liquid. The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard. The conversion was 97%, the yield was 96%, and the by-product 2- (trifluoroethoxy) -4-cyclo-hexyloxy was obtained. -5- (Trifluoromethyl) pyrimidine contained 0.7% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.54 (d, J = 0.8 Hz, 1H), 5.12-5.02 (m, 1H), 4.87 (q, J = 8.1 Hz, 2H), 2.07-1.27 (m, 10H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.55, −74.99 (t, J = 8.1 Hz).
13 C-NMR (CDCl 3 , 100 MHz) δ 166.53, 166.12, 158.38 (q, J = 4.7 Hz), 122.89 (q, J = 275.7 Hz), 122.69 (q, J = 268.9 Hz), 105.79 (q, J = 34.4 Hz), 77.55, 62.90 (q, J = 37.0 Hz), 31.62, 25.49, 23.98.
GC-MS (m / z) 263 (100), 247 (21), 246 (20), 243 (16), 223 (7), 83 (22%).
Elemental analysis calculated: carbon (45.36%), hydrogen (4.10%), nitrogen (8.14%).
Measurements: carbon (45.31%), hydrogen (4.11%), nitrogen (8.12%).
実施例8 2−フェノキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン(9)の調製 Example 8 Preparation of 2-phenoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine (9)
実施例1のベンジルアルコール(0.310g,2.91mmol)に替えてフェノール(0.274g,2.91mmol)を用い、60℃で36時間反応を行った以外、実施例1と同じ操作を行い、2−フェノキシ−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジンの粗製物(1.18g)を無色透明液体として得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率65%、収率58%、副生物の2−(トリフルオロエトキシ)−4−フェノキシ−5−(トリフルロメチル)ピリミジンが収率換算で0.5%含有されていた。
1H−NMR(CDCl3,400MHz)δ8.56(d,J=0.4Hz,1H),7.47−6.46(m,5H),4.92(q,J=8.1Hz,2H)。
19F−NMR(CDCl3,376MHz)δ−63.27,−74.75(t,J=7.5Hz)。
GC−MS(m/z)338(60,M+),319(16),269(11),246(38),192(15),104(20),93(100),77(87%)。
The same operation as in Example 1 was performed except that phenol (0.274 g, 2.91 mmol) was used instead of benzyl alcohol (0.310 g, 2.91 mmol) in Example 1 and the reaction was performed at 60 ° C. for 36 hours. , 2-phenoxy-4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine crude product (1.18 g) was obtained as a colorless transparent liquid. The obtained crude product was subjected to 19 F-NMR measurement using hexafluorobenzene as an internal standard, and the conversion was 65%, the yield was 58%, and the by-product 2- (trifluoroethoxy) -4-phenoxy-5- (Trifluoromethyl) pyrimidine contained 0.5% in terms of yield.
1 H-NMR (CDCl 3 , 400 MHz) δ 8.56 (d, J = 0.4 Hz, 1H), 7.47-6.46 (m, 5H), 4.92 (q, J = 8.1 Hz, 2H).
19 F-NMR (CDCl 3 , 376 MHz) δ-63.27, −74.75 (t, J = 7.5 Hz).
GC-MS (m / z) 338 (60, M + ), 319 (16), 269 (11), 246 (38), 192 (15), 104 (20), 93 (100), 77 (87% ).
比較例1 2,4−ジクロロ−5−(トリフルオロメチル)ピリミジンとリチウム ベンジロキシドの反応
実施例1と同じ反応装置を用い、2,4−ビス(2,2,2−トリクロロエトキシ)−5−(トリフルオロメチル)ピリミジン(1.00g,2.91mmol)に替えて2,4−ジクロロ−5−(トリフルオロメチル)ピリミジン(0.63g,2.91mmol)を用い、0℃で6時間反応を行った以外は実施例1と同じ操作を行い、粗製物(0.86g)を得た。得られた粗製物を、ヘキサフルオロベンゼンを内部標準として用いた19F−NMR測定において、転化率95%で2−ベンジロキシ−4−クロロ−5−(トリフルオロメチル)ピリミジンが収率換算で57%、2−クロロ−5−ベンジロキシ−5−(トリフルオロメチル)ピリミジンが収率換算で35%含有される混合物であった。
Comparative Example 1 Reaction of 2,4-dichloro-5- (trifluoromethyl) pyrimidine and lithium benzyloxide Using the same reaction apparatus as in Example 1, 2,4-bis (2,2,2-trichloroethoxy) -5 (Trifluoromethyl) pyrimidine (1.00 g, 2.91 mmol) was used instead of 2,4-dichloro-5- (trifluoromethyl) pyrimidine (0.63 g, 2.91 mmol), and the reaction was performed at 0 ° C. for 6 hours. The same operation as in Example 1 was carried out except that the crude product (0.86 g) was obtained. In 19 F-NMR measurement using hexafluorobenzene as an internal standard, the obtained crude product was converted into 2-benzyloxy-4-chloro-5- (trifluoromethyl) pyrimidine at a conversion rate of 95% in a yield conversion of 57%. %, 2-chloro-5-benzyloxy-5- (trifluoromethyl) pyrimidine was a mixture containing 35% in terms of yield.
本発明の新規な4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体は、各種医薬品の合成中間体として利用可能であり、5−(トリフルオロメチル)ピリミジン骨格の導入剤として期待される。 The novel 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative of the present invention can be used as a synthetic intermediate for various pharmaceuticals, and 5- (trifluoromethyl) pyrimidine Expected to be a skeleton introduction agent.
Claims (3)
で表される4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体。 The following general formula (1)
A 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative represented by:
RO−M (3)
(式(3)中、Rは前記式(1)に同じ)
で表わされる金属アルコキシド又は金属フェノキシドとを反応させることを特徴とする請求項1に記載の4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体の製造方法。 Following formula (2)
RO-M (3)
(In the formula (3), R is the same as the formula (1))
The method for producing a 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative according to claim 1, wherein the metal alkoxide or metal phenoxide represented by the formula is reacted.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014114123A JP6262079B2 (en) | 2014-06-02 | 2014-06-02 | 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014114123A JP6262079B2 (en) | 2014-06-02 | 2014-06-02 | 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015227318A true JP2015227318A (en) | 2015-12-17 |
JP6262079B2 JP6262079B2 (en) | 2018-01-17 |
Family
ID=54885034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014114123A Active JP6262079B2 (en) | 2014-06-02 | 2014-06-02 | 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6262079B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3328388A (en) * | 1964-09-02 | 1967-06-27 | Merck & Co Inc | Arabinofuranosyl pyrimidines and methods of preparing same |
JP2011515372A (en) * | 2008-03-20 | 2011-05-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Regioselective process for the preparation of substituted pyrimidines |
JP2013501759A (en) * | 2009-08-14 | 2013-01-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
JP2013545741A (en) * | 2010-11-10 | 2013-12-26 | エフ.ホフマン−ラ ロシュ アーゲー | Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
-
2014
- 2014-06-02 JP JP2014114123A patent/JP6262079B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3328388A (en) * | 1964-09-02 | 1967-06-27 | Merck & Co Inc | Arabinofuranosyl pyrimidines and methods of preparing same |
JP2011515372A (en) * | 2008-03-20 | 2011-05-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Regioselective process for the preparation of substituted pyrimidines |
JP2013501759A (en) * | 2009-08-14 | 2013-01-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
JP2013545741A (en) * | 2010-11-10 | 2013-12-26 | エフ.ホフマン−ラ ロシュ アーゲー | Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
Also Published As
Publication number | Publication date |
---|---|
JP6262079B2 (en) | 2018-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6694990B2 (en) | 5- (Trifluoromethyl) pyrimidine derivative and method for producing the same | |
KR101728443B1 (en) | Method for Producing Benzyl Ester 2-aminonicotinicotinate Derivative | |
KR20120117831A (en) | Method for producing 2-amino-4-(trifluoromethyl)pyridine | |
JP6262079B2 (en) | 4- (2,2,2-trifluoroethoxy) -5- (trifluoromethyl) pyrimidine derivative and method for producing the same | |
US8729320B2 (en) | Method for producing difluorocyclopropane compound | |
JPWO2015098717A1 (en) | Process for producing nitro compounds | |
JP5448572B2 (en) | Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound | |
JP6431294B2 (en) | 5- (Trifluoromethyl) pyrimidine derivative and process for producing the same | |
JP4032861B2 (en) | Process for producing β-oxonitrile derivative or alkali metal salt thereof | |
JP6797268B2 (en) | A novel hydroxyphenylboronic acid ester and its production method, and a method for producing a hydroxybiphenyl compound | |
EP3145904A1 (en) | Improved process for preparing substituted crotonic acids | |
KR100968576B1 (en) | Process of preparing 2-acyl-3-amino-2-alkenoate | |
JP4968066B2 (en) | Process for producing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde | |
JP4393839B2 (en) | Preparation of 1,3-di-halo substituted benzene derivatives | |
JP6353772B2 (en) | 2-alkoxy-5- (trifluoromethyl) pyrimidine derivative and method for producing the same | |
KR101548886B1 (en) | Method for preparing (r)-rolipram precursor by catalytic enantioselective micahel reaction and method for preparing (r)-rolptram using the (r)-rolipram precursor | |
JP2016199489A (en) | Method for producing 2-amino-6-methylnicotinic acid ester | |
KR101478597B1 (en) | Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol | |
TW201821400A (en) | Method for manufacturing nitrogen-containing compound | |
JP2009149591A (en) | Process for preparing fluoroalkyl alcohol | |
JPWO2007086559A1 (en) | Method for producing tetrahydropyran compound | |
JP2019135225A (en) | Iodination of aromatic ring by hydrochloric acid solution of monochloroiodine | |
JP2008266183A (en) | Method for producing 3,4-dialkoxy-2-(alkylthio)phenol | |
JPWO2005061478A1 (en) | Process for producing 4-alkoxycarbonyltetrahydropyran or tetrahydropyranyl-4-carboxylic acid | |
JP2008247835A (en) | METHOD FOR PRODUCING METHOXY GROUP-CONTAINING beta-DIKETONE COMPOUND |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170404 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20170404 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20170404 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20171109 |
|
TRDD | Decision of grant or rejection written | ||
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171130 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171206 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171213 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6262079 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |